Title
Treatment of Mucopolysaccharidosis Type II (Hunter syndrome)
Authoring Organization
Publication Month/Year
August 3, 2020
Last Updated Month/Year
April 2, 2024
Document Type
Consensus
External Publication Status
Published
Country of Publication
US
Inclusion Criteria
Female, Male, Adolescent, Child, Infant
Health Care Settings
Ambulatory
Intended Users
Medical techologist technician, genetics, nurse, nurse practitioner, physician, physician assistant
Scope
Management, Treatment
Diseases/Conditions (MeSH)
D016532 - Mucopolysaccharidosis II
Keywords
hunter syndrome, mucopolysaccharidosis, lysosomal storage disease, MPS II
Source Citation
McBride KL, Berry SA, Braverman N; ACMG Therapeutics Committee. Treatment of mucopolysaccharidosis type II (Hunter syndrome): a Delphi derived practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020 Nov;22(11):1735-1742. doi: 10.1038/s41436-020-0909-z. Epub 2020 Aug 3. PMID: 32741966.
Supplemental Methodology Resources
Methodology
Number of Source Documents
57
Literature Search Start Date
December 31, 2015
Literature Search End Date
December 1, 2018